➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Moodys

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Litigation Details for Merck & Cie v. Watson Laboratories Inc. (D. Del. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Merck & Cie v. Watson Laboratories Inc.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Merck & Cie v. Watson Laboratories Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2015-07-02 100 temperature slurry. Claim 4 of U.S. Patent No. 6,441,168 (DTX2, the “’168 Patent”) covers this form, which is…practically insoluble” product of U.S. Patent No. 5,350,850 (the “’850 Patent”), which Watson represents to …refuses to acknowledge what U.S. patent law dictates—the ’850 Patent product is what the law calls a …in the ’850 Patent actually occurred. But they did not. The experiments of the ’850 Patent are paper,…under the patent law. They did not happen. Moreover, the product described in the ’850 Patent is not “ External link to document
2015-08-31 114 alleging infringement of U.S. Patent No. 6,441,168("the'168 patent"). (D.I. 1). Watson filed…#39;850 patent alone or in combination with U.S. Patent No. 5,006,655 ("the '655 patent")… for the '168 patent was filed on April 17, 2000. 2. The '168 patent issued on August …August 27, 2002. 3. The '168 patent was ready for patenting by September 1998. 4. In 1997…procedure in U.S. Patent No. 5,350,850 ("the '850 patent"). C. Conclusions External link to document
2015-08-31 115 alleging infringement of U.S. Patent No. 6,441,168("the'168 patent"). (D.I. 1). Watson filed…#39;850 patent alone or in combination with U.S. Patent No. 5,006,655 ("the '655 patent")… for the '168 patent was filed on April 17, 2000. 2. The '168 patent issued on August …August 27, 2002. 3. The '168 patent was ready for patenting by September 1998. 4. In 1997…procedure in U.S. Patent No. 5,350,850 ("the '850 patent"). C. Conclusions External link to document
2015-09-15 118 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,441,168 B1. (Attachments: #…2013 18 August 2016 1:13-cv-00978 830 Patent None District Court, D. Delaware External link to document
2016-08-18 130 not infringe Claim 4 of U.S. Patent No. 6,441,168 ("the '168 patent"), because that claim…) on the claim in Plaintiffs' complaint for Patent Infringement dated June 4, 2013 (D.I. 1). The…11). Specifically, that Claim 4 of the' 168 patent is invalid for having been on sale in this country…one year prior to the date of application for the patent under 35 U.S.C. § 102(b). 3. …2013 18 August 2016 1:13-cv-00978 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
McKesson
Express Scripts
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.